Booster dose of six Covid vaccines safe, increases immunity: Lancet study
3 years, 1 month ago

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Deccan Chronicle  

New Delhi: Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal. Two doses of AstraZeneca and Pfizer vaccines have shown 79 per cent and 90 per cent protection, respectively, against hospitalisation and death after six months in several studies, the researchers said. "The side effect data show all seven vaccines are safe to use as 3rd doses, with acceptable levels of inflammatory side effects like injection site pain, muscle soreness, fatigue," said Professor Saul Faust, trial lead from the University Hospital Southampton NHS Foundation Trust, UK. "Whilst all boosted spike protein immunogenicity after two doses of AstraZeneca, only AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Janssen and Curevac did so after two doses of Pfizer-BioNTech," Faust said. A randomised, phase 2 trial of the seven booster vaccines was conducted, with the third doses given 10-12 weeks after initial two-dose courses of AstraZeneca or Pfizer-BioNTech.

Vaccines Covid Half Received Response Moderna 28 Days Booster Doses Astrazeneca Pfizer Dose Novavax Two Doses Valneva  half  increases  vaccines  booster  researchers  lancet  safe  dose  response  protection  immunity  pfizer  astrazeneca  doses  covid  seven  study  received

History of this topic

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
8 months ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

Largest Covid vaccine study ever finds shots are linked to small increased risk of neurological, blood and heart disorders - but they are still extremely rare
10 months, 3 weeks ago

Largest Covid vaccine study ever finds shots are linked to small increased risk of neurological, blood and heart disorders - but they are still extremely rare

Daily Mail  

Covid vaccines have been linked to small increases in heart, blood, and neurological disorders, according to the largest global study of its kind. There was also a 1.3 to 1.4 times greater risk of having a seizure following the first and second doses of the Moderna vaccine, as well as the fourth dose of the Pfizer vaccine. Researchers in Israel …

‘Study on covid vaccines’ efficacy soon’
1 year, 8 months ago

‘Study on covid vaccines’ efficacy soon’

Live Mint  

New Delhi: The National Institute of Virology plans to conduct a study to determine the efficacy of vaccines with covid variants. Asked if there’s a need for a 4th dose, Yadav said in an interview, “Before we talk about 4th dose, we should enhance coverage of 3rd precautionary dose to enhance the immune response.” Only about 228.7 million Indians have …

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report
1 year, 11 months ago

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report

Live Mint  

The Union Health Ministry has reiterated that only a small percentage of patients who receive the COVID-19 vaccine may develop serious adverse events depending on certain predisposing circumstances, refuting the reports of various side effects of the vaccine. According to a recent media report, the Central Drugs Standard Control Organization and the Indian Council of Medical Research have acknowledged "multiple …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey
2 years ago

Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey

News 18  

Amid government’s reminders for vaccine boosters in the wake of the Covid uptick in China, 28% of those surveyed by Localcircles said that they “have already taken the booster dose". However, 53% said that they “have not taken the booster dose and do not have any plans of taking it either". After the Centre’s meeting on Wednesday, Niti Aayog’s VK …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 2 months ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 2 months ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

New bivalent Covid vaccines DON'T give people better immunity, studies show
2 years, 2 months ago

New bivalent Covid vaccines DON'T give people better immunity, studies show

Daily Mail  

The new bivalent Covid vaccines are no more effective than the original shots, according to two new studies. In both studies, people who had already been triple vaccinated were given either a standard Covid shot or an updated bivalent booster. President Joe Biden got his updated booster yesterday — his fifth shot to date — in the latest White House …

Covid-19 vaccine study links side effects with greater antibody response
2 years, 2 months ago

Covid-19 vaccine study links side effects with greater antibody response

CNN  

CNN — People who reported experiencing side effects to the Pfizer/BioNTech and Moderna Covid-19 vaccines such as fever, chills or muscle pain tended to have a greater antibody response following vaccination, according to new research. “In conclusion, these findings support reframing postvaccination symptoms as signals of vaccine effectiveness and reinforce guidelines for vaccine boosters in older adults,” the researchers – …

Booster Dose Of Covid-19 Vaccine Highly Effective In Patients With Cirrhosis: Study
2 years, 2 months ago

Booster Dose Of Covid-19 Vaccine Highly Effective In Patients With Cirrhosis: Study

ABP News  

New York, Oct 20 Among cirrhosis patients, receiving a third dose of the vaccine was associated with an 80 per cent reduction in overall Covid-19 and a 100 per cent reduction in the severe course of the infection or death, says a new report. For the study, the team performed a retrospective cohort study of patients with cirrhosis who received …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 7 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

'New plant-based COVID-19 vaccine 70% effective against variants'
2 years, 8 months ago

'New plant-based COVID-19 vaccine 70% effective against variants'

Firstpost  

The vaccine developed by researchers at Canadian biotechnology company Medicago contains coronavirus-like particles produced in plants which are combined with an adjuvant that helps vaccines work better Toronto: A new plant-based COVID-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

In First Quantitative Sero-survey in Mumbai, 99.93% Participants Found with Covid-19 Antibodies
2 years, 8 months ago

In First Quantitative Sero-survey in Mumbai, 99.93% Participants Found with Covid-19 Antibodies

News 18  

In the first quantitative sero-survey conducted in March this year, COVID-19 antibodies were found in 3,097 out of the 3,099 health and frontline workers, who were examined, the Brihanmumbai Municipal Corporation said. Comparatively, more antibodies were found in the blood samples of the employees, who have taken the preventive or booster doses of COVID-19 vaccines as compared to the fully …

New COVID-19 data shows unvaccinated have 'triple' the risk of death compared with fully jabbed
2 years, 8 months ago

New COVID-19 data shows unvaccinated have 'triple' the risk of death compared with fully jabbed

ABC  

South Australian health authorities have released COVID vaccination statistics showing people who are unvaccinated are more than three times as likely to die from the virus than those who've had three doses. Key points: Unvaccinated people have "triple the chance of dying" of those with three or more jabs, SA's health chief said Nicola Spurrier issued the warning ahead of …

Covishield as Booster After 2 Doses of Covaxin Increases Antibodies by 6 Times: Study
2 years, 9 months ago

Covishield as Booster After 2 Doses of Covaxin Increases Antibodies by 6 Times: Study

News 18  

A recent study has found that Covishield is more effective when administered as a booster after two doses of Covaxin as antibodies zoom six-fold, however, the case is not the same when the vaccines are reversed. The study, submitted by Christian Medical College, Vellore, to the Drugs Controller General of India on Wednesday, is the first preliminary scientific evidence from …

Second COVID booster shot does little to stop Omicron, study finds
2 years, 9 months ago

Second COVID booster shot does little to stop Omicron, study finds

LA Times  

Dr. Jacov Lavee receives a fourth dose of the Comirnaty vaccine in Ramat Gan, Israel, as part of a trial to test whether a second COVID-19 booster shot helps protect against infection and illness. Compared to getting two initial doses and one booster shot of Pfizer and BioNTech’s Comirnaty vaccine, adding a second booster shot reduced the rate of coronavirus …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 10 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Three doses of Pfizer Covid vaccine better than two: Study
2 years, 10 months ago

Three doses of Pfizer Covid vaccine better than two: Study

Deccan Chronicle  

Washington: A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of the preventive after one month, a study has found. "When we looked at the effectiveness of the two doses of Pfizer–BioNTech vaccine versus three doses, we see a benefit with three doses that exceeds that achieved with two doses alone," …

Booster shots needed against omicron, CDC studies show
2 years, 11 months ago

Booster shots needed against omicron, CDC studies show

Associated Press  

NEW YORK — Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. The papers echo previous research — including studies in Germany, South Africa and the U.K. — indicating available vaccines are less effective against omicron than earlier versions of the coronavirus, but also …

Omicron News Updates: Schools across Maharashtra to reopen for all classes from 24 Jan, says Varsha Gaikwad
2 years, 11 months ago

Omicron News Updates: Schools across Maharashtra to reopen for all classes from 24 Jan, says Varsha Gaikwad

Firstpost  

12:49 PM Whatsapp Facebook Twitter Omicron News LIVE Updates COVID-19 vaccine booster provides effective antibody protection against Omicron, finds Lancet study A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal. Researchers from Francis Crick Institute and the National Institute for …

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study
2 years, 11 months ago

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study

Firstpost  

COVID-19 Vaccine Booster | The study found that in people who had received the Pfizer vaccine for all three doses, antibody levels against Omicron after a third dose were similar to those previously reached against Delta after only two shots. London: A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of …

COVID-19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID-19 vaccines offer lasting protection, claims study

India TV News  

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19. "This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe," said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition …

How can vaccination status change Covid symptoms? ER doctor explains what to look for
2 years, 11 months ago

How can vaccination status change Covid symptoms? ER doctor explains what to look for

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A New York emergency room doctor has explained which symptoms his …

Why Corbevax, Covovax haven't made the cut for the third dose yet?
2 years, 11 months ago

Why Corbevax, Covovax haven't made the cut for the third dose yet?

India Today  

As the third wave of Covid sweeps over India, the debate of the need for a booster dose rages on. The World Health Organization’s Technical Advisory Group on Covid-19 vaccine composition, in its interim statement on Covid-19 vaccine in the context of the circulation of the Omicron Variant, said: “A vaccination strategy based on repeated booster doses of the original …

Covid-19: Covaxin booster working against Omicron and Delta, says Bharat Biotech
2 years, 11 months ago

Covid-19: Covaxin booster working against Omicron and Delta, says Bharat Biotech

India Today  

Vaccine manufacturer Bharat Biotech said the booster dose of Covaxin has generated robust neutralising antibody responses against both Omicron and Delta, using a live virus neutralisation assay. Test results show that 100 per cent of the serum samples showed neutralisation of the Delta variant and more than 90% of serum samples showed neutralisation of the Omicron variant, Bharat Biotech said. …

Covaxin booster shot may provide long-term immunity against severe Covid, says Bharat Biotech
3 years ago

Covaxin booster shot may provide long-term immunity against severe Covid, says Bharat Biotech

India Today  

A booster dose of Bharat Biotech's Covid-19 vaccine Covaxin, administered six months after the second dose, could provide long-term immunity from severe SARS-CoV-2 infection, a study by Bharat Biotech and the Indian Council of Medical Research - National Institute of Virology, Pune, has indicated. The study, published on medRxiv and not yet peer-reviewed, said that the Covaxin booster shot is …

Booster dose gives high levels of protection against infections from Omicron in older adults: UK study
3 years ago

Booster dose gives high levels of protection against infections from Omicron in older adults: UK study

India Today  

A third top-up booster dose of a Covid-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday. The UK Health Security Agency analysis showed that around three months after the third jab, protection against hospitalisation among those aged 65 and over remains at about 90 per …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?
3 years ago

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?

ABC  

Linda Fisher and her husband Ken are members of Generation AZ: the group of those aged 60+ who lined up for an AstraZeneca vaccine, the only one available to their age group for some time. "If Omicron didn't exist you would probably feel pretty relaxed around Christmas this year," he says. "Most people have a certain degree of immunity which …

Booster increases antibodies, improves protection against Omicron: Scientists
3 years ago

Booster increases antibodies, improves protection against Omicron: Scientists

Deccan Chronicle  

New Delhi: A booster dose against COVID-19 raises the amount of circulating antibodies and is shown to increase protection from symptomatic infection with Omicron, scientists have said, underlining that boosters can be the simplest step forward, especially for the immunosuppressed. Reacting to the statement of UK Health Security Agency that booster dose of Covishield vaccine is effective against Omicron and …

Boosters DO beat Omicron and cut risk of falling ill by 75%
3 years ago

Boosters DO beat Omicron and cut risk of falling ill by 75%

Daily Mail  

Booster Covid jabs offer up to 75 per cent protection against mild illness caused by the super Omicron variant, official UK Government analysis revealed tonight. It estimated that a Pfizer booster provides between 70 and 75 per cent protection against mild Omicron illness, regardless of which vaccine was originally used, compared to 90 per cent for Delta. The analysis showed …

Booster Shot of Pfizer Covid Vaccine Can Cut Mortality from Delta Variant by 90%: Study
3 years ago

Booster Shot of Pfizer Covid Vaccine Can Cut Mortality from Delta Variant by 90%: Study

News 18  

The third dose of the Pfizer COVID-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel. Among participants 65 years of age or older, death from COVID-19 occurred in 60 of 470,808 participants in the booster group and in 123 of 35,208 participants in the …

Expert Panel To Meet Today To Discuss Covid-19 Booster
3 years ago

Expert Panel To Meet Today To Discuss Covid-19 Booster

ABP News  

New Delhi: The Subject Expert Committee will be meeting today to discuss the requirement of a booster shot for high-risk people, reported ANI. The National Technical Advisory Group on Immunization had held a meeting earlier this week to discuss vaccination for children and additional doses. “The meeting put light on COVID-19 vaccination, additional doses, and vaccination for children but due …

Mix and matching some COVID vaccines gives high immunity: Study
3 years, 1 month ago

Mix and matching some COVID vaccines gives high immunity: Study

Al Jazeera  

Oxford University study finds mixing a first dose of the Pfizer or Astrazeneca vaccine with a second Moderna shot yields higher antibodies. “I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they’re still rolling out the first two doses of vaccines,” Snape said. “We’re showing … you don’t have to …

Coronavirus Updates: Maharashtra Reports 2 More Omicron Cases in Mumbai; Both Asymptomatic
3 years, 1 month ago

Coronavirus Updates: Maharashtra Reports 2 More Omicron Cases in Mumbai; Both Asymptomatic

News 18  

Maharashtra on Monday reported two more Omicron cases, taking the total number of infections due to the new Covid-19 variant to 10. The issue of administering ‘additional’ dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon in the meeting of the National Technical Advisory Group on Immunisation scheduled to be held on December 6, official sources said. In …

SII Seeks Approval for Covishield Boosters: Is there Enough Data?
3 years, 1 month ago

SII Seeks Approval for Covishield Boosters: Is there Enough Data?

The Quint  

While Serum Institute of India cited UK's MHRA giving the green light for AstraZeneca booster doses, they left out certain other key points. For one, around the same time, higher ups at AstraZeneca had warned against rushing into giving booster doses for all before 2 dose data is adequately studied. Expressing their reservations, Pascal Soriot, chief executive, and Sir Mene …

Boosters short: The Hindu Editorial on third COVID-19 vaccination dose
3 years, 1 month ago

Boosters short: The Hindu Editorial on third COVID-19 vaccination dose

The Hindu  

On November 22, the Director-General, ICMR, said that there was no scientific evidence thus far to administer a booster vaccine dose to fully vaccinated people. The Health Minister too said the priority was on fully vaccinating all adults than on booster shot immunisation though adequate vaccines were available. Despite these uncertainties, it might still be prudent to approve booster doses …

Protection offered by booster shot beats ‘natural immunity,’ study suggests
3 years, 1 month ago

Protection offered by booster shot beats ‘natural immunity,’ study suggests

LA Times  

Michael Stremfel prepares a COVID-19 booster shot at Flintridge Pharmacy in La Cañada Flintridge. A new study finds that people who got a booster shot generated much higher levels of neutralizing antibodies than people who had a coronavirus infection. A small study that’s among the first to track people’s protective antibodies over time found that those who were immunized against …

No need for booster dose for now, third COVID wave of magnitude compared to first two unlikely, says AIIMS chief
3 years, 1 month ago

No need for booster dose for now, third COVID wave of magnitude compared to first two unlikely, says AIIMS chief

Firstpost  

On the need for a booster dose, AIIMS director Dr Randeep Guleria said there is no surge in cases as such at the moment which suggests that vaccines are still protecting against coronavirus. New Delhi: A third Covid wave of a magnitude comparable to the first two is unlikely to hit India, AIIMS director Dr Randeep Guleria said Tuesday as …

Covaxin shows 50% effectiveness against symptomatic Covid-19, says Lancet study
3 years, 1 month ago

Covaxin shows 50% effectiveness against symptomatic Covid-19, says Lancet study

India Today  

Two doses of Covaxin are 50 per cent effective against the symptomatic disease, according to the first real-world assessment of India's indigenous Covid-19 vaccine published in The Lancet Infectious Diseases journal. Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and …

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief
3 years, 1 month ago

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief

Firstpost  

According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory Group on Immunisation in India New Delhi: There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, ICMR director general Dr Balram Bhargava said on Monday underlining the completion of second …

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla
3 years, 1 month ago

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla

News 18  

Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat in overcoming the COVID-19 pandemic while urging all adults to get vaccinated at the earliest. He said that 200 million doses of the COVID-19 vaccine were lying with the states and people should get themselves vaccinated as soon as possible. Vaccine hesitancy is now …

Covid booster vaccine halves risk of catching virus
3 years, 1 month ago

Covid booster vaccine halves risk of catching virus

The Telegraph  

People who have had a booster jab are half as likely to test positive for Covid than those who had their second dose six months ago, new figures from the Office for National Statistics show. The latest data also revealed that unvaccinated people are five times more likely to be infected than those who have had their top-up jab. In …

Covaxin 77.8% Effective Against Covid-19, 65.2% Against Delta Variant: Lancet Study
3 years, 1 month ago

Covaxin 77.8% Effective Against Covid-19, 65.2% Against Delta Variant: Lancet Study

News 18  

Covaxin, a Covid-19 vaccine developed by Hyderabad-based Bharat Biotech, was found to have a 77.8% efficacy rate against symptomatic Covid-19, as per an analysis published in The Lancet. The roll-out of Covaxin can “increase the finite global manufacturing capacity, and improve the insufficient supply of vaccines which disproportionately affects low-income and middle-income countries”, said Chinese researchers Li Jingxin Li and …

Health council advises third vaccine dose for over-60s
3 years, 2 months ago

Health council advises third vaccine dose for over-60s

Dutch News  

People over 60 or living in residential care should be offered a third vaccine dose to boost their immunity against coronavirus, the Dutch health council has advised. Booster jabs should be made available six months after people had their last vaccine dose. Other countries including the USA and Israel started giving booster shots in September, while the UK is offering …

Health council advises third vaccine dose for over-60s
3 years, 2 months ago

Health council advises third vaccine dose for over-60s

Dutch News  

People over 60 or living in residential care should be offered a third vaccine dose to boost their immunity against coronavirus, the Dutch health council has advised. Booster jabs should be made available six months after people had their last vaccine dose. Other countries including the USA and Israel started giving booster shots in September, while the UK is offering …

Discover Related